Literature DB >> 18470718

Procalcitonin-a new diagnostic tool in complications following liver transplantation.

E R Kuse1, I Langefeld, K Jaeger, W R Külpmann.   

Abstract

OBJECTIVE: Does procalcitonin (PCT) allow differentiation between infection and rejection following liver transplantation in the case of fever of unknown origin (FUO)?
DESIGN: Open prospective trial.
SETTING: transplant intensive care unit at a university hospital. PATIENTS: Forty patients after liver transplantation.
INTERVENTIONS: Liver biopsy for diagnosis of rejection, transcutaneous aspiration cytology for monitoring of lymphocyte activation. MEASUREMENTS: Procalcitonin from EDTA plasma, APACHE II, Sepsis, score (Elbute and Stoner).
RESULTS: Eleven patients suffered an infectious complication resulting in an increase in PCT levels (2.2-41.7 ng/ml). Eleven patients developed a rejection episode; none of these patients showed a rise in PCT levels. The statistical difference between PCT levels in rejection and infection was significant (p<0.05) on the day of diagnosis.
CONCLUSION: PCT allows differentiation between rejection and infection in the case of FUO. Elevation of PCT plasma levels develops early postoperatively due to operation trauma, and, in the case of FUO with no rise in PCT, a rejection may be suspected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470718     DOI: 10.1007/BF02900736

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  18 in total

1.  Fatal haemorrhage following liver biopsy in patients with HIV infection.

Authors:  D R Churchill; D Mann; R J Coker; R F Miller; G Glazer; R D Goldin; S B Lucas; J N Weber; K M De Cock
Journal:  Genitourin Med       Date:  1996-02

2.  Letter: Hypersecretion of calcitonin in neoplastic conditions.

Authors:  G Milhaud; C Calmette; J Taboulet; A Julienne; M S Moukhtar
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

3.  Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection.

Authors:  D C Snover; D K Freese; H L Sharp; J R Bloomer; J S Najarian; N L Ascher
Journal:  Am J Surg Pathol       Date:  1987-01       Impact factor: 6.394

4.  Tissue polypeptide specific antigen, neopterin, and CRP for monitoring heart transplant recipients.

Authors:  M Vogl; S E Andert; M M Müller
Journal:  Clin Biochem       Date:  1995-06       Impact factor: 3.281

5.  Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients.

Authors:  P J McLaughlin; A Aikawa; H M Davies; R G Ward; A Bakran; R A Sells; P M Johnson
Journal:  Transplantation       Date:  1991-06       Impact factor: 4.939

6.  Procalcitonin in patients with and without immunosuppression and sepsis.

Authors:  B al-Nawas; P M Shah
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

7.  Neopterin excretion after liver transplantation and its value in differential diagnosis of complications.

Authors:  H Tilg; W Vogel; W E Aulitzky; D Schönitzer; R Margreiter; O Dietze; G Judmaier; H Wachter; C Huber
Journal:  Transplantation       Date:  1989-10       Impact factor: 4.939

8.  Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation.

Authors:  H Tilg; J Nordberg; W Vogel; T A Luger; M Herold; W E Aulitzky; R Margreiter; C Huber
Journal:  Transplantation       Date:  1992-07       Impact factor: 4.939

9.  Fine-needle aspiration biopsy in the monitoring of liver allografts. II. Applications to human liver allografts.

Authors:  I Lautenschlager; K Höckerstedt; J Ahonen; B Eklund; H Isoniemi; C Korsbäck; E Pettersson; K Salmela; T M Scheinin; E von Willebrand
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

10.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  6 in total

1.  Legionella pneumonia and serum procalcitonin.

Authors:  Laura Franzin; Daniela Cabodi
Journal:  Curr Microbiol       Date:  2004-10-28       Impact factor: 2.188

2.  Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

Authors:  R Arkader; E J Troster; M R Lopes; R R Júnior; J A Carcillo; C Leone; T S Okay
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

3.  Procalcitonin for infections in the first week after pediatric liver transplantation.

Authors:  Vladimir L Cousin; Kalinka Lambert; Shahar Trabelsi; Annick Galetto-Lacour; Klara M Posfay-Barbe; Barbara E Wildhaber; Valérie A McLin
Journal:  BMC Infect Dis       Date:  2017-02-15       Impact factor: 3.090

4.  Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies.

Authors:  Felix Krenzien; Eriselda Keshi; Katrin Splith; Silvan Griesel; Kaan Kamali; Igor M Sauer; Linda Feldbrügge; Johann Pratschke; Annekatrin Leder; Moritz Schmelzle
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

5.  Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.

Authors:  Yang-Ching Ko; Wen-Pin Wu; Chi-Sen Hsu; Mong-Ping Dai; Chien-Chih Ou; Chih-Hsiung Kao
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

6.  [The diagnosis of sepsis].

Authors:  L Engelmann
Journal:  Intensivmed Notfallmed       Date:  2006
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.